APP下载

Meetings and Courses

2014-03-31Shui-YingLei

Meetings and Courses

Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication. This list is provided as a service to readers; inclusion does not imply endorsement by the HBPD INT.

Section editor

Shui-Ying Lei

Email: hbpdje@mail.hz.zj.cn

September

8th ILCA annual conference

September 5-7, 2014; Kyoto, Japan

The 8th ILCA annual conference of the International Liver Cancer Association (ILCA) aims to: 1) committe to promoting basic, clinical, translational, multidisciplinary and multi-national liver cancer research, including the development of clinical trials; 2) foster and encourage scientific exchange and dissemination of knowledge; 3) strive to educate physicians, scientists, allied healthcare professionals and the general public at large; 4) educate international and national health authorities on the diagnosis, prevention and management of liver cancer; 5) value collaboration with other learned societies, governmental organizations, professional associations, groups, institutions and individuals who contribute to progress in the field. For more information, please contact: International Liver Cancer Association (ILCA), Avenue de Tervueren, 300, B-1150 Brussels, Belgium. Tel: +32-0-2-789-2345; Fax: +32-0-2-743-1550; Email: info@ilca-online.org. Website: http://www.ilca2014.-org/.

AASLD/EASL special conference on hepatitis C

September 12-13, 2014; Sheraton New York, New York, USA

The objectives of this conference are to: 1) evaluate the impact of new strategies for screening of hepatitis C in the United States and abroad; 2) understand the changing global epidemiology of HCV infection; 3) recognize the role and limitations of non-invasive tests for staging hepatic fibrosis; 4) understand the strengths and limitations of recently approved therapeutic regimens compared to first generation triple therapy regimens; 5) understand barriers to care and identify potential solutions to improve global access to new HCV therapies. For more information, please visit: http://www.aasld.org/ additionalmeetings/Pages/hcvspecialconference.aspx.

2nd world congress on controversies in gastroenterology (CIGI)

September 12-14, 2014; Xi'an, China

The 2nd CIGI congress aims to circulate up-to-date information and provide unique opportunities for world leaders within the field to debate most vital and contentious issues in the field of gastroenterology and endoscopy. This thought-provoking academic dialogue will bring to light the most current clinical and technological questions. The scientific program will include overviews, state of the art lectures and controversial debates. The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment. Through these exciting discussions, key issues will be raised and provide practitioners with tailored recommendations regarding patient care. For more information, please contact: Headquarters & Administration: 53 Rothschild Boulevard, PO Box 68, Tel Aviv, 6100001, Israel. Tel: +972-3-5666166; Fax: +972-3-5666177; Email: Info@comtecmed.com. Comtec China: Suite 405, Universal Center Building, 175 Xiangyang Road South, Shanghai 200031, China. Tel: +86-21-54660460; Fax: +86-21-54660450; Email: china@ comtecmed.com. Website: www.comtecmed.com/CIGI.

19th international symposium on endoscopic ultrasonography

September 18-20, 2014; ITC Grand Chola, Chennai, India

The 19th International Symposium on Endoscopic Ultrasonography (EUS 2014) will present a comprehensive overview of the rapidly changing EUS landscape. The world's preeminent professionals will be converging in the research hub of Chennai, India, to share their knowledge, wisdom and experience. EUS2014 will have two components: A two-day program that will include live demonstrations of basic and advanced EUS procedures combined with state-of-the art lectures and a half day program specially designed for beginners that will include practical tutorials by experts. Live demonstrations will include radial examinations, fine needle aspiration techniques interpreted in real-time by cytopathologists as well as interventional procedures. The future environment within gastrointestinal endoscopy dictates that we not only be efficient in our practice but also remain as self-sufficient as possible. Therefore, a major focus of this symposium will be on EUS-related cytopathology to enable endosonographers to independently assess for diagnostic adequacy. For general inquiry please contact: Symposium Secretariat, Kenes India Conferences Pvt. Ltd. Aggarwal Complex, 301 3rd Floor, LSC, A-1/B Janakpuri, New Delhi-110058.Tel: +91-11-45199100; Fax: +91-11-25513052; Email: info@ eus2014.org. Website: http://eus2014.org/.

13th annual AACR international conference on frontiers in cancer prevention research

September 28-October 1, 2014; Sheraton New Orleans Hotel, New Orleans, La., USA

This annual conference fosters collaborations between all disciplines of prevention research, accelerates the progression in the field of prevention research, and promotes awareness of the vital importance of cancer prevention in reducing cancer incidence and mortality. The theme for this year's conference is "From Cells to Society." All sessions will be cross-cutting and themes such as metabolism will be touched upon throughout the conference. Several short proffered talks will also be selected from submitted abstracts and integrated into thematic sessions. Continuing Medical Education Activity AMA PRA Category 1 CreditsTMare available. For more information, please visit: http://www.aacr.org/ Meetings/Pages/MeetingDetail.aspx?EventItemID=22#. U8OFDtKSywV.

November

The Liver Meeting® 2014: postgraduate course--Clinical implications of inflammation and immunity in acute and chronic liver disease and patient care

November 7-8, 2014; Hynes Convention Center, Boston, Massachusetts, USA

Course directors are Gyongyi Szabo, MD, PhD; Kyong-Mi Chang, MD; and Naga Chalasani, MD. This course will provide a comprehensive update on major scientific advancements and state-of-the-art medical approaches in hepatology related to the management of patients with liver disease. Information provided at the course will improve care of individual patients and promote liver health. The objectives of this course are to: 1) identify the relevant immune-mediated events contributing to liver pathology and the progression of liver disease; 2) effectively assess needs for early intervention and management in patients with liver diseases with inflammatory components; 3) prevent progression of chronic liver disease by effective use of immunosuppressives, antiviral agents, bile salt therapies. For more information, please visit: http://www.aasld. org/additionalmeetings/Pages/lmpgcourse14.aspx.

The science of cancer health disparities in racial/ethnic minorities and the medically underserved

November 9-12, 2014; Grand Hyatt San Antonio, San Antonio, Texas, USA

The AACR cancer health disparities conferences advance the understanding and, ultimately, help to eliminate the disparities in cancer that represent a major public health problem in USA. By promoting the exchange of novel ideas and information between a wide range of professionals from academia, industry, government, and the community, these conferences harness the potential and maximize the many opportunities for bringing research on health disparities from bench to bedside or community, and back again. The goals of these conferences have been to bring together scientists and other professionals working in a variety of disciplines to discuss the latest findings in the field and to stimulate the development of new research in cancer health disparities. For more information, please visit: http://www.aacr.org/Meetings/Pages/MeetingDetail. aspx?EventItemID=23#.U8OGx9KSywU.

December

Tumor immunology and immunotherapy: a new chapter

December 1-4, 2014; Disney's Contemporary Resort, Orlando, Fla., USA

This AACR special conference is designed to provide highly stimulating discussions to further the scientific and translational goals of the field and allow for more effective exchange of ideas among basic cancer immunologists, non-immunologists, and clinical scientists. The central theme of this year's conference is to discuss the advances made in basic and translational tumor immunology across multiple disciplines. Important topics to be covered in this meeting are: interaction of radiobiology, antibody effector mechanisms in immune therapy, tumor microenvironment, microbiome, overcoming obstacles to generating adaptive immunity, adoptive-T-cell therapy, metabolism, and novel understanding in the biology of vaccination. For more information, please visit: http://www.aacr.org/Meetings/Pages/MeetingDetail. aspx?EventItemID=26#.U8OFadKSywU.

10.1016/S1499-3872(14)60289-7)